Karleen Habin
- Oncology top 10%
- Cancer Treatment and Pharmacology 5
- Cancer survivorship and care 3
- PARP inhibition in cancer therapy 3
-
- Breast Cancer Treatment Studies 4
- Cancer Genomics and Diagnostics 4
-
- BRCA gene mutations in cancer 7
- Estrogen and related hormone effects 3
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Eric P. WinerLeif W. EllisenBeth OvermoyerNadine TungVincent L. GirandaMeghan Underhill‐BlazeySJ IsakoffPaul E. Goss
- Cited by
- OncologyCancer ResearchGenetics
- Journals
- Journal of Clinical Oncology (7 papers)Clinical journal of oncology nursing (5 papers)Oncology nursing forum (3 papers)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Karleen Habin
25 papers receiving 498 citations
Peers
Comparison fields: 5 of 74
- Oncology 311
- Cancer Research 156
- Genetics 132
- Pulmonary and Respiratory Medicine 122
- Family Practice 8
Countries citing papers authored by Karleen Habin
This map shows the geographic impact of Karleen Habin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karleen Habin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karleen Habin more than expected).
Fields of papers citing papers by Karleen Habin
This network shows the impact of papers produced by Karleen Habin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karleen Habin. The network helps show where Karleen Habin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karleen Habin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 15 | |
| 2 | 2020 | 0 | |
| 3 | 2020 | 3 | |
| 4 | 2018 | 1 | |
| 5 | 2017 | 11 | |
| 6 | 2017 | 11 | |
| 7 | 2017 | 6 | |
| 8 | 2016 | 6 | |
| 9 | 2016 | 28 | |
| 10 | 2016 | 5 | |
| 11 | 2014 | 5 | |
| 12 | 2011 | 10 | |
| 13 | 2010 | 32 | |
| 14 | 2010 | 20 | |
| 15 | 2010 | 122 | |
| 16 | 2009 | 9 | |
| 17 | 2008 | 115 | |
| 18 | 2008 | 30 | |
| 19 | 2007 | 14 | |
| 20 | 2005 | 1 |
About Karleen Habin
Karleen Habin is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Radiation, having authored 27 papers that have together received 520 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (7 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers), Cancer Genomics and Diagnostics (4 papers), Estrogen and related hormone effects (3 papers), Cancer survivorship and care (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Oncology (311 citations), Cancer Research (156 citations), Genetics (132 citations), Pulmonary and Respiratory Medicine (122 citations) and Family Practice (8 citations). Karleen Habin has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Eric P. Winer, Leif W. Ellisen, Beth Overmoyer, Nadine Tung, Vincent L. Giranda, Meghan Underhill‐Blazey, SJ Isakoff, Paul E. Goss, R. S. Gelman and Daniel A. Haber. Their work appears in journals such as Journal of Clinical Oncology, Clinical journal of oncology nursing, Oncology nursing forum, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.